Close
Biotechgate
| |

Home Page

Action required: Please refresh your browser

We have recently implemented some changes that require a hard refresh of your browser: Please hold down the CTRL-key and press the F5 key.
After a successful hard refresh, this message should not appear anymore.

More details about this topic are available here »

News in the Life Sciences Industry

Results 2161 - 500 out of 500 displayed.
«  1  2  3  4  5  6  7  8  9  10  11  12  13  14  15  16  17  18  19  20  21  22  23  24  25
Reset 

Nxera Pharma: Notice of Issuance of New Shares Under the Restricted Stock Unit (RSU) Plan and Determination of Payment Amount and Other Matters of Issuance of New Shares Under Previous Years’ RSU Plan

Read more ››
By: GlobeNewswire - 17 Apr 2024
Related companies:  Nxera Pharma Co., Ltd.

BioCryst Announces Approval of ORLADEYO® (berotralstat) by the Brazilian Health Regulatory Agency

Read more ››
By: GlobeNewswire - 17 Apr 2024
Related companies:  BioCryst Pharmaceuticals, Inc.

Enterome Announces Successful Completion of Phase 2 ROSALIE Study of EO2401 in Recurrent Glioblastoma

Read more ››
By: GlobeNewswire - 17 Apr 2024
Related companies:  Enterome S.A.

Medigene to Present at Upcoming Scientific Conferences

Read more ››
By: GlobeNewswire - 17 Apr 2024
Related companies:  Medigene AG

GILEAD SCIENCES JOIN FORCES WITH WORLD HEPATITIS ALLIANCE AND EXPERTS TO AWARD US$4 MILLION ALL4LIVER GRANT FOR VIRAL HEPATITIS ELIMINATION BY 2030, INCLUDING TWO INNOVATIVE INITIATIVES IN ASIA

Read more ››
By: PR Newswire Association LLC. - 17 Apr 2024
Related companies:  Gilead Sciences, Inc.

Q1 2024 Revenue and Business Update

Read more ››
By: PR Newswire Association LLC. - 17 Apr 2024
Related companies:  Telix Pharmaceuticals Limited

Novartis Kesimpta® six-year efficacy data show substantial benefits in recently diagnosed treatment-naïve people with relapsing multiple sclerosis

Read more ››
By: PR Newswire Association LLC. - 17 Apr 2024
Related companies:  Novartis Pharmaceuticals Corporation

CS Analytical Continues Capital Investment -Announces Installation of Large-Scale Temperature and Humidity Test Chambers

Read more ››
By: PR Newswire Association LLC. - 17 Apr 2024

Prostate Cancer: Advancements in Prevention and Treatment Drive Global Market Growth

Read more ››
By: PR Newswire Association LLC. - 17 Apr 2024

Viral Vector and Plasmid DNA Technologies: A Global Market Perspective

Read more ››
By: PR Newswire Association LLC. - 17 Apr 2024

75% OF WOMEN AGES 18-59 EXPERIENCED MULTIPLE PELVIC HEALTH ISSUES IN THE PAST YEAR ACCORDING TO A NEW STUDY BY ORIGIN AND IPSOS

Read more ››
By: PR Newswire Association LLC. - 17 Apr 2024

SOPHiA GENETICS Announces Unilabs is using its AI Technology to Detect Homologous Recombination Deficiency (HRD)

Read more ››
By: PR Newswire Association LLC. - 17 Apr 2024

Orexo extends patent protection for its nasal epinephrine powder product OX640 in the US

Read more ››
By: PR Newswire Association LLC. - 17 Apr 2024
Related companies:  Orexo AB

SyntheticMR and SimonMed Expand Trials of Synthetic MRI Testing and Announce Upcoming Expansion of Synthetic Availability from SyntheticMR's SyMRI NEURO Software at SimonMed Facilities

Read more ››
By: PR Newswire Association LLC. - 17 Apr 2024
Related companies:  SyntheticMR AB

Xeltis Announces Latest Results from aXess Trials to be Presented at 46th Annual Charing Cross Symposium

Read more ››
By: PR Newswire Association LLC. - 17 Apr 2024
Related companies:  Xeltis BV

TScan Therapeutics Announces Pricing of Upsized $150 Million Public Offering

Read more ››
By: GlobeNewswire - 17 Apr 2024
Related companies:  TScan Therapeutics, Inc.

Press Release: New 48-week frexalimab phase 2 data support potential for high sustained efficacy in multiple sclerosis

Read more ››
By: GlobeNewswire - 17 Apr 2024
Related companies:  Sanofi SA

Idorsia publishes a Financial Status required for an upcoming bondholder meeting

Read more ››
By: GlobeNewswire - 17 Apr 2024
Related companies:  Idorsia Ltd

SCG CELL THERAPY AND A*STAR LAUNCH JOINT LABS WITH COLLABORATION NEARING S$30 MILLION TO ADVANCE iPSC TECHNOLOGY TOWARDS SCALABLE GMP MANUFACTURING OF CELLULAR IMMUNOTHERAPIES

Read more ››
By: PR Newswire Association LLC. - 17 Apr 2024
Related companies:  SCG Cell Therapy Pte Ltd

Mississippi Enacts Critical Reform to Improve Access to Care for the 1 in 10 State Residents Living with a Rare Disease

Read more ››
By: PR Newswire Association LLC. - 17 Apr 2024
«  1  2  3  4  5  6  7  8  9  10  11  12  13  14  15  16  17  18  19  20  21  22  23  24  25
to the top ↑